Senate's Bipartisan Rx Pricing Probe Seeks Documents Regarding FDA Regs
• By Scott Steinke
Probe launched by the Senate Aging panel asks four manufacturers – Valeant, Turing, Retrophin and Rodelis – for documents pertaining to pricing their products, but also wants to know how they may have analyzed FDA regs to help them avoid competition.
A Senate committee has turned what was primarily a Democrat campaign against high drug prices into a bipartisan concern and is also pulling FDA regulations into the discussion.
